EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of AdaptHealth Corp.

July 30, 2021 5:33 PM EDT | Source: Levi & Korsinsky, LLP

New York, New York--(Newsfile Corp. - July 30, 2021) -  Levi & Korsinsky notifies investors that it has commenced an investigation of AdaptHealth Corp. ("AdaptHealth" or the "Company") (NASDAQ: AHCO) concerning possible violations of federal securities laws.

On July 19, 2021, Jehoshaphat Research published a report alleging that AdaptHealth is a company that is built primarily through the acquisition of smaller companies with common services or products, that obscures its organic growth by "[r]etroactively changing past organic growth numbers to be higher, with no disclosure about the change." It was also suggested that AdaptHealth's manipulation of its organic growth trajectory was "a blatant violation of non-GAAP disclosure rules, for which companies get into huge trouble."

On this news, AdaptHealth's stock price fell $1.51 per share, or 5.93%, to close at $23.96 per share on July 19, 2021. To obtain additional information, go to:

https://www.zlk.com/pslra-1/adapthealth-corp-f-k-a-dfb-healthcare-acquisitions-corp-loss-submission-form

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7091/91778_91ecbc8934c54ab0_001full_200.jpg

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/91778

info